2 Top Biotech Buyout CandidatesZacks Investment Research • about 1 month agoAfter a strong resurgence in the back half of 2023 and continued momentum into the first quarter of 2024, biotech stocks are back in vogue. “Hawkish” Federal Reserve Policy, a brutal bear...